Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Appointment of Chief Financial Officer
Effective January 10, 2023, the board of directors of Lucira Health, Inc. (the
"Company") appointed Richard Narido to serve as Chief Financial Officer.
Mr. Narido has been serving as the Company's interim Chief Financial Officer as
well as principal financial officer and principal accounting officer since
November 15, 2022, and he will continue in the roles of principal financial
officer and principal accounting officer. The disclosures required by Form 8-K
Item 5.02(c)(2) and (3) are included in Item 5 of the Company's Quarterly Report
on Form 10-Q filed on November 14, 2022.
Mr. Narido will be eligible to participate in the Company's Officer Severance
Benefit Plan, a copy of which is incorporated by reference as Exhibit 10.5 to
the Company's Annual Report on Form 10-K for the year ended December 31, 2021,
filed with the SEC on March 31, 2022. Mr. Narido will enter into the Company's
standard form of Indemnity Agreement for directors and executive officers of the
Company.
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses
LUCIRA HEALTH, INC. 
